147 related articles for article (PubMed ID: 8359058)
1. [Soft tissue tumors: indications and results of hyperthermia].
Issels RD; Bosse D; Starck M; Abdel-Rahman S; Jauch KW; Schildberg FW; Wilmanns W
Chirurg; 1993 Jun; 64(6):461-7. PubMed ID: 8359058
[No Abstract] [Full Text] [Related]
2. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
[TBL] [Abstract][Full Text] [Related]
3. Preoperative doxorubicin plus ifosfamide in primary soft-tissue sarcomas of the extremities.
Azzarelli A; Quagliuolo V; Casali P; Fissi S; Montalto F; Santoro A
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S210-2. PubMed ID: 8453700
[TBL] [Abstract][Full Text] [Related]
4. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Demetri GD; Elias AD
Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide combination regimens for soft-tissue sarcoma.
Stuart-Harris R; Dalley D; Bell DR; Levi J; Simes RJ; Wiltshaw E
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695
[TBL] [Abstract][Full Text] [Related]
6. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for patients with soft tissue sarcoma.
Ozaki T; Sugihara S; Hamada M; Nakagawa Y; Inoue H
Hiroshima J Med Sci; 1993 Sep; 42(3):109-15. PubMed ID: 8253605
[TBL] [Abstract][Full Text] [Related]
8. [Regional hyperthermia with systemic chemotherapy in children and adolescents: feasibility and clinical follow-up of 34 intensively pretreated patients with prognostically unfavorable tumor diseases].
Romanowski R; Schött C; Issels R; Klingebiel T; Treuner J; Jürgens H; Göbel U; Goldschmitt-Wuttge B; Feldmann H; Haas R
Klin Padiatr; 1993; 205(4):249-56. PubMed ID: 8377446
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative chemotherapy in treatment of soft tissue sarcoma].
Rosen G; Eilber F; Eckardt J; Holmes C; Forscher CA; Lowenbraun S; Selch M; Fu YS
Chirurg; 1993 Jun; 64(6):443-8. PubMed ID: 8359055
[No Abstract] [Full Text] [Related]
10. Ifosfamide in soft tissue sarcoma.
Zaidi SH; Iqbal Z; Mallick JA
J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
[No Abstract] [Full Text] [Related]
11. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
12. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
Schlag PM; Kettelhack C
Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
[No Abstract] [Full Text] [Related]
13. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
[TBL] [Abstract][Full Text] [Related]
14. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
Schuetze SM; Patel S
Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
16. [Solid tumors in young patients].
Hartmann JT; Lorch A
Onkologie; 2011; 34 Suppl 5():12-6. PubMed ID: 21921662
[No Abstract] [Full Text] [Related]
17. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
Schütte J; Kellner R; Seeber S
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of postoperative adjuvant chemotherapy and radiotherapy for soft-tissue sarcoma.
Fuchs R; Schadeck-Gressel C; Makoski HB; von Andrian-Werburg HF; Knieriem HJ; Westerhausen M
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S199-203. PubMed ID: 8453698
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials].
Budach V
Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407
[No Abstract] [Full Text] [Related]
20. Chemotherapy for soft-tissue sarcomas.
Elias AD
Clin Orthop Relat Res; 1993 Apr; (289):94-105. PubMed ID: 8472436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
